China enters CAR-T cell therapy era

被引：9

作者：

Cao, Xin ^{[1
,3
,5
]}

Li, Wei ^{[2
,3
,4
,5
]}

Yu, Yiyi ^{[2
,3
,5
]}

Liu, Tianshu ^{[2
,3
]}

Zhou, Yuhong ^{[2
,3
,4
]}

机构：

[1] Fudan Univ, Inst Clin Sci, Zhongshan Hosp, Shanghai 200032, Peoples R China

[2] Fudan Univ, Dept Med Oncol, Zhongshan Hosp, Shanghai 200032, Peoples R China

[3] Fudan Univ, Zhongshan Hosp, Ctr Canc, Shanghai 200032, Peoples R China

[4] Fudan Univ, Zhongshan Hosp, Cell Therapy Ctr, Shanghai 200032, Peoples R China

[5] Fudan Univ, Zhongshan Hosp, Clin Trial Ctr, Shanghai 200032, Peoples R China

来源：

INNOVATION | 2022年 / 3卷 / 01期

关键词：

D O I：

10.1016/j.xinn.2021.100197

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页数：2

共 5 条

[1] Recent advances and discoveries in the mechanisms and functions of CAR T cells
Larson, Rebecca C.
Maus, Marcela V.
[J]. NATURE REVIEWS CANCER, 2021, 21 (03) : 145 - 161
[2] Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Locke, Frederick L.
Ghobadi, Armin
Jacobson, Caron A.
Miklos, David B.
Lekakis, Lazaros J.
Oluwole, Olalekan O.
Lin, Yi
Braunschweig, Ira
Hill, Brian T.
Timmerman, John M.
Deol, Abhinav
Reagan, Patrick M.
Stiff, Patrick
Flinn, Ian W.
Farooq, Umar
Goy, Andre
McSweeney, Peter A.
Munoz, Javier
Siddiqi, Tanya
Chavez, Julio C.
Herrera, Alex F.
Bartlett, Nancy L.
Wiezorek, Jeffrey S.
Navale, Lynn
Xue, Allen
Jiang, Yizhou
Bot, Adrian
Rossi, John M.
Kim, Jenny J.
Go, William Y.
Neelapu, Sattva S.
[J]. LANCET ONCOLOGY, 2019, 20 (01) : 31 - 42
[3] To Embrace Open Science More Closely
Ning, Bi
Zhao, Yan
[J]. INNOVATION, 2020, 1 (01):
[4] Immunogenicity of CAR T cells in cancer therapy
Wagner, Dimitrios L.
Fritsche, Enrico
Pulsipher, Michael A.
Ahmed, Nabil
Hamieh, Mohamad
Hegde, Meenakshi
Ruella, Marco
Savoldo, Barbara
Shah, Nirali N.
Turtle, Cameron J.
Wayne, Alan S.
Abou-el-Enein, Mohamed
[J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (06) : 379 - 393
[5] Clinical Response of CD19 CAR-T Cells (relmacabtagene autoleucel, relma-cel) in Adults with Heavily-Pre-Treated Relapsed/Refractory (r/r) Large B-Cell Lymphoma in China
Zhu, Jun
Ying, Zhitao
Song, Yuqin
Yang, Haiyan
Guo, Ye
Li, Wenyu
Zou, Dehui
Zhou, Daobin
Wang, Zhao
Zhang, Mingzhi
Wu, Jianqiu
Liu, Hui
Zhang, Pian
Yang, Su
Zhou, Zisong
Zheng, Hongxia
[J]. BLOOD, 2020, 136

← 1 →